Our study extends these findings, whether or not received radiotherapy or chemotherapy prior to surgery therapy, we found that elevated pre-surgical hs-cTnI levels occur in colorectal cancer patients are associated with increased risk of all-cause death. Here, TNNI3 is linked to colorectal cancer.